Holocene Advisors’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,132,873
| Closed | -$7.4M | – | 821 |
|
|
2023
Q3 | $7.4M | Hold |
2,132,873
| – | – | 0.03% | 313 |
|
|
2023
Q2 | $9.92M | Hold |
2,132,873
| – | – | 0.04% | 252 |
|
|
2023
Q1 | $9.85M | Sell |
2,132,873
-180,669
| -8% | -$835K | 0.05% | 233 |
|
|
2022
Q4 | $18.7M | Sell |
2,313,542
-491,655
| -18% | -$3.97M | 0.11% | 186 |
|
|
2022
Q3 | $15.6M | Hold |
2,805,197
| – | – | 0.1% | 195 |
|
|
2022
Q2 | $14.6M | Buy |
2,805,197
+973,442
| +53% | +$5.07M | 0.09% | 192 |
|
|
2022
Q1 | $15.1M | Buy |
1,831,755
+248,176
| +16% | +$2.04M | 0.08% | 198 |
|
|
2021
Q4 | $23.6M | Sell |
1,583,579
-23,887
| -1% | -$355K | 0.12% | 182 |
|
|
2021
Q3 | $30.4M | Buy |
1,607,466
+10,584
| +0.7% | +$200K | 0.17% | 157 |
|
|
2021
Q2 | $29.7M | Buy |
1,596,882
+173,677
| +12% | +$3.23M | 0.17% | 144 |
|
|
2021
Q1 | $32.4M | Buy |
1,423,205
+355,947
| +33% | +$8.1M | 0.2% | 134 |
|
|
2020
Q4 | $23.2M | Buy |
+1,067,258
| New | +$23.2M | 0.15% | 178 |
|